Benefit of the detailed educational white papers related to our products, technologies, methodologies, and clinical applications. Research findings, questions and tips, and specific highlights are now within reach to support your daily activities in the clinical field.
The role of Artificial Intelligence in the Echocardiography workflow
Cardiovascular diseases are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, valvular heart diseases, and other conditions. According to the World Health Organization, an estimated 17.9 million people die of cardiovascular diseases each year.
HyperDoppler Intracardiac flow dynamics
Intracardiac flow analysis is a different way to look at cardiac function providing incremental and additive information to conventional approaches based on cardiac mechanics. The HyperDoppler is easy to use, intuitive in terms of data provided, and complete in terms of parameters offered.
PX 1-5 diamond single crystal technology
Esaote has developed the PX 1-5, an elegant and easy-to-use probe, to deliver enhanced echocardiography performance and workflows, increasing the level of patient care. The Esaote PX 1-5 phased array probe features a sophisticated acoustic model to achieve superb imaging performance, even in technically difficult patients
Evaluation of Function and Structure of a Venous Stent
3D Imaging can show complicated structures in peripheral vessels that otherwise could only be seen by CT. In contrast to CT, these structures can be looked at in real-time, under comfortable conditions, both for the patient and the examiner, giving the option to show and measure flows at the same time.
Ultrasound CV technologies for Heart Failure
Heart failure (HF) is a leading cause of cardiovascular morbidity and mortality worldwide. It has a prevalence of about 1-2% in the adult population of developed countries, reaching ≥ 10% among people > 70 years of age. More than 1 million people are hospitalized annually for HF, with 5-year mortality rates of approximately 50%.
An insight in EACVI-ASE-Industry Initiative to Standardize Deformation Imaging
Deformation imaging, based on Speckle Tracking techniques, is a promising technology for the evaluation and quantification of cardiac mechanics. In particular, during the last decade, a growing body of scientific evidences has shown that this technology, can provide incremental information in many clinical settings.
Vascular Biomarkers in Cardiovascular Risk Prediction
The use of cardiovascular biomarkers in conjunction with risk scores is expected to refine the risk stratification of an individual subject and to guide his therapy. Biomarker is a characteristic that is objectively measured and that reflects early functional and structural changes in cardiovascular system...
XSTRAIN™ 4D
2D STE represents a new approach to quantitative assessment of the cardiac function, delivering incremental prognostic information over traditional clinical parameters. By combining 2D STE data gathered from multiple cardiac views, we have developed a further step ahead in the interpretation of LV deformation index, making it easier and faster than ever.
Prevention Suite
Atherosclerosis is a systemic disease that remains asymptomatic for decades. With the integration of heart-vessel study (carotid IMT and stiffness with cardiac deformation index and coronary flow) we could draw a new roadmap to diagnose an early and personalized CVD risk assessment.
iQProbes - Technical Perspectives on Broadband Ultrasound Transducers
Improvements in Diagnostic Imaging Resolution and Penetration: ultrasound probes are comprised of a transducer, housing, cable, and system connector. Esaote probe design optimizes each of these components to ensure best-in-class clinical performance, ergonomics, and reliability.
RF-QIMT & RF-QAS Atherosclerosis in Diabetology
New radio frequency echo-tracking technology provides real-time automated and highly accurate carotid intima-media thickness (IMT) and indices of large artery stiffness and endothelial function. In adolescents with type 1 diabetes mellitus (T1DM) this technique may be used to reveal very early atherosclerotic involvement, as well as to help monitoring adequacy of glycemic control and limiting incident cardiovascular complications.
RF-QIMT & RF-QAS
RF-Data provides physicians with extra help in the risk assessment of cardiovascular desease (CVD) and target organ damage (TOD). Accuracy, ease of use and reliability are the core of this innovative technological tool.
EHD Technology
Diagnostic value enhancement and system usability optimization are the main key factors taken into consideration in the development of the eHD Technology. It focuses the whole ultrasound chain, from the transducer to the display, passing through signal processing and strategic features.